Symptoms are common among patients receiving treatment for advanced cancers, yet are undetected by clinicians up to half the time. There is growing interest in integrating electronic patient-reported outcomes (PROs) into routine oncology practice for symptom monitoring, but evidence demonstrating clinical benefit has been limited
The National Cancer Institute’s Common Terminology Criteria for Adverse Events (NCI-CTCAE) reporting...
PURPOSE: Adverse event (AE) reporting is essential in clinical trials. Clinician interpretation can...
BACKGROUND: Patients with advanced, incurable cancer receiving anticancer treatment often experience...
There is growing interest to enhance symptom monitoring during routine cancer care using patient-rep...
Symptom management is a cornerstone of quality oncology care. Most patients with cancer experience d...
Among patients receiving treatment for advanced cancers, symptoms are common and frequently cause di...
Digital symptom monitoring via electronic patient-reported outcomes (PROs) has been demonstrated in ...
PURPOSE There is increasing interest in implementing digital systems for remote monitoring of patien...
Objectives: Patients with lung cancer have high symptom burden and diminished quality of life. Elect...
Aims: People living with treatable but not curable cancer often experience a range of symptoms rela...
Symptom monitoring during chemotherapy via web-based patient-reported outcomes (PROs) was previously...
BACKGROUND: Many cancer patients experience high symptom burden. Healthcare in the USA is reactive, ...
BACKGROUND: Many cancer patients experience high symptom burden. Healthcare in the USA is reactive, ...
BACKGROUND: Many cancer patients experience high symptom burden. Healthcare in the USA is reactive, ...
The National Cancer Institute’s Common Terminology Criteria for Adverse Events (NCI-CTCAE) reporting...
The National Cancer Institute’s Common Terminology Criteria for Adverse Events (NCI-CTCAE) reporting...
PURPOSE: Adverse event (AE) reporting is essential in clinical trials. Clinician interpretation can...
BACKGROUND: Patients with advanced, incurable cancer receiving anticancer treatment often experience...
There is growing interest to enhance symptom monitoring during routine cancer care using patient-rep...
Symptom management is a cornerstone of quality oncology care. Most patients with cancer experience d...
Among patients receiving treatment for advanced cancers, symptoms are common and frequently cause di...
Digital symptom monitoring via electronic patient-reported outcomes (PROs) has been demonstrated in ...
PURPOSE There is increasing interest in implementing digital systems for remote monitoring of patien...
Objectives: Patients with lung cancer have high symptom burden and diminished quality of life. Elect...
Aims: People living with treatable but not curable cancer often experience a range of symptoms rela...
Symptom monitoring during chemotherapy via web-based patient-reported outcomes (PROs) was previously...
BACKGROUND: Many cancer patients experience high symptom burden. Healthcare in the USA is reactive, ...
BACKGROUND: Many cancer patients experience high symptom burden. Healthcare in the USA is reactive, ...
BACKGROUND: Many cancer patients experience high symptom burden. Healthcare in the USA is reactive, ...
The National Cancer Institute’s Common Terminology Criteria for Adverse Events (NCI-CTCAE) reporting...
The National Cancer Institute’s Common Terminology Criteria for Adverse Events (NCI-CTCAE) reporting...
PURPOSE: Adverse event (AE) reporting is essential in clinical trials. Clinician interpretation can...
BACKGROUND: Patients with advanced, incurable cancer receiving anticancer treatment often experience...